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Abstract
Background: Multiple micronutrient deficiencies are highly prevalent among preschool children and often lead to anemia
and growth faltering. Given the limited success of supplementation and health education programs, fortification of foods
could be a viable and sustainable option. We report results from a community based double-masked, randomized trial
among children 1–4 years evaluating the effects of micronutrients (especially of zinc and iron) delivered through fortified
milk on growth, anemia and iron status markers as part of a four group study design, running two studies simultaneously.
Methods and Findings: Enrolled children (n=633) were randomly allocated to receive either micronutrients fortified milk
(MN=316) or control milk (Co=317). Intervention of MN milk provided additional 7.8 mg zinc, 9.6 mg iron, 4.2 mg selenium,
0.27 mg copper, 156 mg vitamin A, 40.2 mg vitamin C, and 7.5 mg vitamin E per day (three serves) for one year.
Anthropometry was recorded at baseline, mid- and end-study. Hematological parameters were estimated at baseline and
end-study. Both groups were comparable at baseline. Compliance was over 85% and did not vary between groups.
Compared to children consuming Co milk, children consuming MN milk showed significant improvement in weight gain
(difference of mean: 0.21 kg/year; 95% confidence interval [CI] 0.12 to 0.31, p,0.001) and height gain (difference of mean:
0.51 cm/year; 95% CI 0.27 to 0.75, p,0.001). Mean hemoglobin (Hb) (difference of 13.6 g/L; 95% CI 11.1 to 16.0, p,0.001)
and serum ferritin levels (difference of 7.9 mg/L; 95% CI 5.4 to 10.5, p,0.001) also improved. Children in MN group had 88%
(odds ratio=0.12, 95% CI 0.08 to 0.20, p,0.001) lower risk of iron deficiency anemia.
Conclusions/Significance: Milk provides an acceptable and effective vehicle for delivery of specific micronutrients, espe-
cially zinc and iron. Micronutrient bundle improved growth and iron status and reduced anemia in children 1–4 years old.
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Introduction
Undernutrition and anemia impact health, growth, develop-
ment and survival of young children in the low-income countries
[1,2]. Growth stunting affects 182 million children younger than
five years old and over 50% of children have anemia [3,4].
Deficiency of essential micronutrients is one of the commonest
attributable causes [5,6]. Micronutrient deficiency in turn can
increase the risk and/or severity of morbidities and anorexia,
thereby further depleting micronutrient stores, adversely affecting
the hematological parameters and impairing physical growth
[4,7,8]. In first three years of life, hematopoesis and rapid growth
represent a highly active metabolic state requiring several
micronutrients thus making them vulnerable to deficiency. Recent
evidence suggests that delivery of specific multiple micronutrient
combinations as compared to single micronutrient may have a
greater beneficial effect on iron stores, hematological parameters
and growth [9–12].
National level supplementation programs and health education
to change dietary practices in preschool children have achieved
limited success in alleviating micronutrient deficiencies in
vulnerable populations. Implementation costs, frequency of
administration and hence lack of adherence to supplementation,
complexities of changing feeding behavior and lack of options that
would deliver optimal bio-available iron and zinc [13–15] could be
the reasons for limited success of supplementation programs. On
the other hand, encouraging results from fortification intervention
trials and the national level fortification programs (in Brazil and
Chile) have identified fortification of common home-based foods
as an attractive alternative [16–18].
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12167We undertook a community-based, doubled-masked random-
ized trial with four arms to evaluate the effect of two different milk
interventions in comparison to their respective control groups
(essentially running two trials concurrently with a common
randomization). Two groups evaluated impact of fortifying regular
milk powder with micronutrient bundle in comparison to same
milk without fortification; and the other two groups evaluated
fortification of pre-fortified premium milk with prebiotic and
probiotic in comparison to same milk without pre and probiotics
fortification. In this paper we are reporting the results of the two
arms evaluating efficacy of consumption of multiple micronutri-
ents (including iron and zinc) fortified milk for a period of one year
on growth, body iron stores and anemia among children aged 1–4
years. The results of the other two arms are reported separately in
a companion paper [19].
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Participants
The trial was carried out from April 2002 to April 2004, in
Sangam Vihar, a peri-urban community located on the outskirts of
New Delhi, India. Detailed population description has previously
been reported [20]. Center for Micronutrient Research has been
maintaining a regularly updated comprehensive demographic
database of Sangam Vihar for over a decade. From the database,
all permanent resident families in the area with children aged 1–3
years were invited to participate in the study, and their consent
sought. Children who were exclusively or predominantly breast
fed or allergic to milk were excluded. Children with severe
malnutrition needing rehabilitation or chronic/severe illness
requiring hospitalization or special treatment were to be excluded;
however, none of the children contacted met this criterion. At
enrollment, all children who had severe anemia (hemoglobin [Hb]
,70 g/L) were given therapeutic dose of iron for 3 months in
addition to their assigned intervention.
Ethics
The human research and ethical review committees at the Johns
Hopkins University, USA and the Annamalai University, India
approved the study protocol. The purpose of the study along with
the possible risks and benefits associated was read out and
explained to the parents in the local language, and informed
written consent obtained. Procedure consisted of supervisor
visiting the household and in presence of a third party, obtaining
the consent from the mother or father after reading the consent
form to them. Parents were given a choice to sign the consent form
or if they were illiterate and/or could not sign, supervisor and the
witness signed to document the consent.
This procedure had been approved by both institutional review
boards’ as majority of the mothers cannot sign in this population
and taking thumb impression is stigmatized due to misuse during
colonial era.
Procedures
Mothers were requested to bring the child to the study clinic for
baseline assessment. At enrolment, the study physician carried out
a detailed physical examination of the child and collected the
socio-economic and demographic information of the household.
Weight was measured to the nearest 10 g with an electronic
scale (SECA Corporation, Columbia, MD/ATCO weighing
Solutions Company Limited, India) by two independent observers,
and height was recorded to nearest 0.1 cm using height boards
(Shorr Productions, Olney, MD). The weight and height of the
child was measured at enrollment, after 6 months (mid-study) and
one year of intervention (end-study).
A venous blood sample was collected using a trace element-free
syringe, immediately transferred into ethylenediaminetetraacetic
acid vial for a detailed hemogram and zinc protoporphyrin (ZnPP)
analysis, and zinc-free heparin vials for plasma zinc estimation.
Plasma was separated within 15 minutes of blood collection, and
aliquots were transferred into trace element-free Eppendorf plastic
tubes for storage at 220uC. The ethylenediaminetetraacetic blood
was analyzed on the same day with a Coulter automated flow
cytometer (Beckman-Coulter, Fullerton, CA) for a detailed
hemogram. One drop of blood was used for estimating ZnPP
using a front face hematofluorometer (Aviv Biomedical, Lakewood
NJ). Plasma zinc estimations were performed by standard methods
using atomic absorption spectrometer (AAS 800-Perkin Elmer)
[21]. Serum ferritin (sFr) and serum transferrin (sTfr) were
estimated from plasma samples using a commercial enzyme linked
immunosorbent assay kit (Spectro Ferritin Kit, Spectro Transfer-
rin Kit; Ramco Laboratories, Inc., Houston, Texas). Biochemical
analyses were repeated after one year of intervention.
Intervention
Fonterra Brands (Singapore) Pte. Ltd. provided 32 g single serve
sachets of fortified milk powder and control for the study. At
enrollment, the procedure for preparing milk was clearly explained
and demonstrated to mothers. Each week, the milk assistants
delivered 21 sachets at home and advised the mother to feed the
child 3 sachets a day. Composition of milk in intervention and
control groups is given in Table 1. Fortified milk (3 servings per
day) was designed to deliver additional amounts of zinc (7.8 mg),
iron (9.6 mg), selenium (4.2 mg), copper (0.27 mg), vitamin A
(156 mg), vitamin C (40.2 mg), vitamin E (7.5 mg) while the
control milk powder provided natural levels of the specific
micronutrients as in base milk without additional fortification of
zinc or iron. Intervention continued for a year. Mothers were
advised to continue breast-feeding for children who were breastfed
and to continue giving whatever other supplementary feeding the
child was taking. The timing of milk feeds in relation to other
feeding was not controlled and was decided by mother.
Outcomes
Primary outcomes were not explicitly pre-specified in the
protocol; the intent was to evaluate the impact on morbidity,
growth, development, iron status and anemia. However, the
sample size was estimated based on the effects on diarrhoea and
pneumonia. We have already reported the effect of micronutrient-
fortified milk on the morbidity outcomes [20]. In this paper we are
reporting the effect on growth, anaemia and iron status.
The effect on growth parameters was evaluated by estimating
the mean change in Z-scores at end-study from baseline and gain
in weight/height over a period of 1 year of supplementation.
Stunting was defined as height for age (HAZ) ,22 Z-scores,
wasting as weight for height (WHZ) ,22 Z-scores and
underweight as weight for age (WAZ) ,22 Z-scores [22]. The
effect of intervention compared to control on iron status and
anemia was evaluated by estimating the difference of means from
baseline to end-study for each of the hematological parameters
[Hb, Hematocrit (Hct), ZnPP, Red cell distribution width (RDW),
sFr, sTfr] and the change in proportion of iron deficient anemic
children from baseline to end-study.
Micronutrient-Anemia & Growth
PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12167Children with Hb #100 g/L were considered anemic, and iron
deficient state was defined as the presence of 2 or more of the
following criteria: sFr #12mg/L, sTfr .8.3 mg/ml, Hct #30%
and ZnPP $80 mmol per mole of heme. Iron deficiency anemia
was categorized as Hb #100 g/L and the presence of two or more
of four conditions of iron deficiency.
Sample Size and Power
The sample size estimation for morbidity related outcomes,
which was highest and drove sample size, has been described
previously [20]. The sample size was estimated based on the
assumption that micronutrient bundle would decrease diarrhea
incidence by 15% and episodes of pneumonia by 25% with alpha
of 0.05 and 90% power. This sample size provided a power of
more than 90% to detect a change in anthropometric indices of
0.5 Z-score over the baseline Z-scores, at a=0.05. It also provided
a power of more than 90% to detect a change in mean Hb level by
5.0 g/L over the baseline Hb.
Randomization: Sequence Allocation and Allocation
Concealment
The study consisted of two trials run concurrently with common
randomization. Letter codes A through D were used to identify
four groups (across two separate trials). In-house computer
software generated a random sequence of group codes with
permuted block length of 16. Two separate randomization lists -
one for children with baseline Hb .70 g/L and another for
children with baseline Hb #70 g/L were used. After enrollment,
each child was classified into two strata based on their baseline Hb
and allocated the next available serial number and the letter code
within that hemoglobin strata.
Blinding and Implementation
The supplementation sachets were identical in colour, size
(weight 32 g), taste and packaging and were labelled with a letter
code. The investigators and the study team were blinded to the
identity of the letter codes. Fonterra Brands Pte. Ltd. provided
code identification to investigators after finishing of the trial, at the
time of analysis. In the field, the letter code of the supplementation
sachets was covered with label providing child’s identification
information.
Data Management and Statistical Analysis
We used Visual Basic 6.0 and Oracle 8i to manage our data,
with stringent range, consistency, and logical checks. Real time
data entry ensured data quality and accuracy. We used double
data entry and manual checking of frequencies during data
cleaning before the code was broken. For primary analysis, we
used alphabetical codes for groups still blinded to real group
identity. The groups were assessed for comparability at baseline.
The statistical significance for the group differences of continuous
variables was established using a Student’s t-test, and of categorical
variables by chi-square test. We applied logistic regression using
WAZ ,22.0 Z-score ‘Yes/No’ as dependent variable and
baseline WAZ scores and group allocation as independent
variables. Stratified analysis based on gender and age was carried
out to understand the gender and age differences between the
intervention and control groups. Multiple linear regression models
were designed to examine the independent effect of fortification on
weight and height gain after adjusting for other covariates like
SES, maternal education, gender, age at baseline, baseline plasma
zinc levels and anemia status.
The analyses were performed in STATA 9.2 (Stata Corp.,
College Station, Texas, USA), and SPSS 12.0 (SPSS Inc.,
Chicago, Illinois, USA). Anthropometric Z-scores were calculated
using WHO standards [22]. Intent to treat analysis was performed
and all children enrolled were included in the analysis, irrespective
of compliance. For withdrawals, we included all data available
until withdrawal.
Results
In this paper we are presenting the results of one year
intervention of micronutrient fortified milk on growth and iron
indices of children allocated to two of the four letter codes i.e.
micronutrient fortified milk (MN) and its control (Co).
Table 1. Composition of micronutrient fortified milk vs.
control milk (cheap regular milk used as base milk).
Nutritive value
(3 serves per day)
Micronutrient Milk
Group (MN)
Control Group
(Co)
Energy (kJ) 1890 1890
Protein (g) 20.1 20.1
Taurine (mg) 48 48
Carbohydrate (g) 48.9 48.9
Fat (g) 18.9 18.9
Vitamin A
a (mg) 330 174
Vitamin D3 (mg) 3.6 3.6
Vitamin E
b (mg) 8.1 0.6
Vitamin C (mg) 48 7.8
Thiamin (mg) 0.6 0.6
Riboflavin (mg) 1.8 1.8
Niacin (mg) 4.5 4.5
Vitamin B6 (mg) 0.6 0.6
Pantothenic Acid (mg) 2.7 2.7
Folate (DFE)
c (mg) 114 114
Vitamin B12 (mg) 2.7 2.7
Biotin (mg) 24.9 24.9
Choline (mg) 114 114
Calcium (mg) 720 720
Phosphorus (mg) 600 600
Magnesium (mg) 84 84
Iron (mg) 9.6 0
Zinc (mg) 9.6 1.8
Iodine (mg) 36 36
Selenium (mg) 6.6 2.4
Copper (mg) 0.3 0.03
Sodium (mg) 360 360
Potassium (mg) 1260 1260
Chloride (mg) 900 900
aRetinol activity equivalents.
ba - tocopherol equivalents.
cDietary folate equivalents.
Milk Ingredients: Skim milk, added carbohydrate, Cream, Sucrose, Lactose,
Corn oil, Lecithin, Vanillin, Vitamins: Vitamin A, Vitamin D3, Vitamin E, Thiamin
hydrochloride, Pyridoxine hydrochloride, Vitamin C, Folate, Niacinamide,
Minerals: Ferrous sulphate, Zinc sulphate, Copper sulphate (Fortified milk
contains additional fortification of Zinc, Iron, Vitamin A, Vitamin E, Vitamin C,
Selenium and Copper).
doi:10.1371/journal.pone.0012167.t001
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Out of 660 eligible children, 27 (parents/caretakers) refused to
participate. The enrolled children were randomly allocated to
receive either micronutrient-fortified milk (MN group; n=316) or
the same milk with natural levels of micronutrients (Co group;
n=317) (Figure 1).
Baseline Data
At baseline, the study groups were comparable for socio-
economic, demographic, hematological and anthropometric
parameters (Table 2). Among enrolled children, 66.8% in MN
and 62.4% in Co group were moderately anemic (Hb: 70.1–
100 g/L); 87.4% in MN and 85.7% in Co group had signs of iron
deficient hematopoesis (ZnPP: .80 mmol/mole of heme); and
58.2% in MN and 50.3% in Co group were iron deficient anemic.
Almost 68% of children were experiencing growth faltering.
Compliance
The compliance (adherence to study milk feeds) was assessed by
collecting the information on consumption of milk and the
Figure 1. Schematic flow of the participants in the study.
doi:10.1371/journal.pone.0012167.g001
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year intervention period. The median adherence to the interven-
tion was over 85% in both groups. The mean number of sachets
consumed per day was 2.58 in the intervention group and 2.54 in
the control group. No adverse episode due to consumption of milk
was reported during the course of the study.
Effect on Growth
Compared to children consuming the non-fortified milk,
children consuming MN milk, on an average gained 0.21 kg/yr
(95% CI 0.12 to 0.31, p,0.001) in weight and 0.51 cm/yr (95%
CI 0.27 to 0.75, p,0.001) in height. After 1 year of intervention,
children in the fortified milk group showed a significant
improvement in the WHZ, WAZ and HAZ scores (Table 3).
Corrected for baseline Z-score, consumption of fortified milk
resulted in a significant decrease in the proportion of children with
WAZ ,22 Z-scores [MN vs. Co: odds ratio=0.63 (95% CI 0.40
to 0.99), p=0.05]. The growth effects observed at 6 months are
presented in supplementary Table S1.
After adjusting for the socio-economic status, maternal
education, gender, baseline age, anemia and zinc status, children
in the fortified group on an average gained more weight (0.23 kg/
yr; 95% CI 0.12 to 0.33, p,0.001) and height (0.58 cm/yr; 95%
CI 0.33 to 0.82, p,0.001) (Table 4).
Effect on Body Iron Stores and Anemia
Compared to children consuming control milk, children consum-
ing fortified milk had significant improvement in anemia and
repletion of body iron stores (Table 5). Mean Hb levels increased by
13.6 g/L (95% CI 11.1 to 16.0, p,0.001) in the fortified milk group
as compared to the control group. Consumption of fortified milk
resulted in 88% decrease in the proportion of children with iron
deficiency anemia (95% CI 80% to 92%, p,0.001).
The improvement in Hb levels was consistent with improve-
ment in hematocrit and erythrocytic markers. Fortified milk
resulted in significant lowering of mean ZnPP, mean RDW and an
increase in mean hematocrit (Table 5). Fortified milk supplemen-
tation resulted in a decrease in proportion of children with
markedly elevated ZnPP levels (.80 mmol/mole of heme; MN vs.
Co: 33.5% vs. 72%) and elevated RDW levels (RDW .14%; MN
vs. Co: 85.4% vs. 97%). Fortified milk consumption compared to
consumption of control milk, resulted in an increase in mean body
iron stores (sFr) and a significant reduction in mean total iron
binding capacity (sTfr) (Table 5).
The overall changes in the serological markers, erythrocytic
indices, and the hemoglobin resulted in a significant reduction in
the proportion of iron deficient children [MN vs. Co: 68 (29.2%)
vs. 164 (70.7%), p,0.001].
Subgroup analyses by age and gender did not reveal any
differential effect (data not presented) of fortified milk on
hematological parameters.
Discussion
Our results suggest that milk is a good and well-accepted
vehicle for the delivery of zinc, iron and other micronutrients
Table 2. Baseline characteristics of children included in the study.
Variables Category MN Group (n=316) Co Group (n=317)
Age (mo)
a - 22.466.8 23.066.7
Illiterate father
b - 54 (17.1) 52 (16.4)
Illiterate mother
b - 168 (53.2) 169 (53.3)
Occupation father Daily wage labor
b 114 (36.1) 106 (33.4)
Occupation mother Housewives
b 308 (97.5) 307 (96.8)
Socio-economic status score
a -7 . 1 62.7 7.362.5
Hematological markers
c Hemoglobin
a (g/L) 89.2615.0 91.0614.9
Hematocrit
a (%) 30.364.0 31.064.4
Zinc protoporphyrin
a (mmol/mole of heme) 214.46134.5 212.76135.3
Red cell distribution width
a (%) 19.462. 8 19.262.6
Sr ferritin
a (mg/L) 8.668.0 9.368.2
Sr transferrin
a (mg/ml) 15.669.1 14.969.1
Iron deficient anemic
b,d 171 (58.2) 154 (50.3)
Plasma zinc
a (mg/dL) - 60.7623.3 62.6626.8
Anthropometric parameters Weight
a (kg) 9.0861.5 9.0361.5
Height
a (cm) 78.265.7 78.065.8
Normal
b 102 (32.3) 104 (32.8)
Wasted and stunted
b 55 (17.4) 46 (14.6)
Stunted
b,e 149 (47.0) 147 (46.5)
Wasted
b,e 10 (3.2) 20 (6.3)
aMean6standard deviation.
bNumber (%).
cThe cut offs for defining anemia and iron deficiency that are conventionally used are Hb #100 g/L, Hct #30%, ZnPP $80 mmol per mole of heme, RDW .14%,
SFr #12mg/L, STfr .8.3 mg/ml.
dAt least 2 parameters for defining iron deficiency were available in only 294 children in MN group and 306 children in Co group.
eStunting refers to stunting only, ie without wasting and wasting refers to wasting only, ie without stunting.
doi:10.1371/journal.pone.0012167.t002
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observed high compliance rate over 1 year study period. The
effect of milk fortified with specific micronutrients (zinc, iron,
selenium, copper, vitamins A, C and E) compared to control
milk for 1 year on growth, Hb levels, body iron stores in this
study is a conservative estimate as both groups got 3 servings of
milk in addition to their regular diet. In the interpretation of
results we need to consider, that the base milk used was regular
cheap milk with no added iron and only 1.8 mg of zinc
(Table 1).
There is inconclusive evidence about the impact of iron and
zinc fortification on anemia and iron status. Meta-analysis of 21
data sets from iron supplementation randomized controlled trials
in children aged 0 to 12 years reported a significant difference in
the mean change in Hb concentrations between treatment and
control groups of 7.8 g/L, or an effect size of 1.49 (95% CI 0.46
to 2.51) [23]. In our trial, we observed a larger impact on iron
status markers with iron fortification than in iron supplementa-
tion trials. Among children consuming fortified milk, the median
Hb levels improved by 17 g/L compared to their baseline Hb
levels. Similar beneficial effects have been reported by other
fortification trials conducted in low-income countries [12,18,
24–26]. Availability of vitamin A and other co-factors like
riboflavin, B-12 and folic acid essential for erythropoiesis [27]
could have resulted in larger overall improvement of hematolog-
ical parameters. Presence of vitamin C in the fortified
micronutrient bundle, potentiating bioavailability of iron may
have contributed to this impact.
Although available data from published trials are not
conclusive, it is postulated that zinc may reduce the beneficial
effects of iron on iron status [11]. The observed effect on iron
status markers suggests that delivering zinc and other micronu-
trients with iron via fortified food either enhances (in the presence
of ascorbic acid) or does not interfere with the absorption and
bioavailability of iron. In our trial, we did not observe any
difference in plasma zinc concentrations between the groups.
Whether that is due to negative impact of iron on bioavailability
of zinc or limitation of plasma zinc not being a good marker of
zinc status can only be surmised. The beneficial effects on
morbidity reported earlier [20], observed anthropometric out-
comes, which are commonly attributable to zinc intake rather
than iron [9,28], and ZnPP change would argue for an
improvement in zinc status which plasma zinc was not able to
reflect.
Table 3. Effect of fortification on anthropometric parameters among fortified milk vs. control milk group children after 1 year of
intervention.
Variables MN Group (n=267)
a Co Group (n=257)
a
Difference of means
(95% CI) p value
Weight velocity
c (kg/yr) 2.1360.58
b 1.9260.55 0.21 (0.12 to 0.31) ,0.001
Height velocity
d (cm/yr) 8.6061.40 8.1061.37 0.51 (0.27 to 0.75) ,0.001
Change in Z-scores between baseline and end-study
Difference in WHZ score
e 0.4260.65 0.3060.65 0.13 (0.02 to 0.24) 0.03
Difference in WAZ score
f 0.3860.54 0.1860.51 0.20 (0.11 to 0.29) ,0.001
Difference in HAZ score
g 0.2860.47 0.0960.42 0.19 (0.12 to 0.27) ,0.001
aEnd-study anthropometry data were available for 267 and 257 children in the MN and Co group respectively.
bMean6SD.
cRate of gain in body weight over a period of 1 year of intervention.
dRate of gain in height over a period of 1 year of intervention.
eWeight for height Z-score.
fWeight for age Z-score.
gHeight for age Z-score.
doi:10.1371/journal.pone.0012167.t003
Table 4. Multiple linear regression
a evaluating the effect of micronutrient fortification on weight velocity and height velocity of
children after 1 year of intervention.
Variables Weight velocity (n=425) Height velocity (n=425)
B 95% CI p value B 95% CI p value
Micronutrient fortification 0.23 0.12 to 0.33 ,0.001 0.58 0.33 to 0.82 ,0.001
Socio-economic status 20.01 20.03 to 0.008 0.23 0.04 20.003 to 0.09 0.07
Maternal education 20.18 20.18 to 0.03 0.15 0.02 20.23 to 0.27 0.87
Gender 20.006 0.00 to 0.09 0.91 20.11 20.36 to 0.14 0.38
Age at baseline 20.02 20.03 to 20.01 ,0.001 20.08 20.096 to 20.06 ,0.001
Plasma zinc at baseline 20.004 20.006 to 20.002 0.001 20.003 20.008 to 0.002 0.23
Severe anemia 0.16 20.03 to 0.34 0.09 0.36 20.07 to 0.78 0.10
R
2 (model summary) 0.11 - ,0.001 0.18 - ,0.001
aAdjusted for socio-economic status, maternal education, gender, age at baseline, plasma zinc levels at baseline and anemia status at baseline.
doi:10.1371/journal.pone.0012167.t004
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trients and frequent infections among children in developing
countries have been suggested as causes of growth faltering
[29]. In our trial, both preparations of milk provided 1890 kJ
of energy and 20 g of dairy protein, and yet micronutrient
fortified group showed improved weight and height gain.
These findings would suggest that energy and protein without
micronutrients is not sufficient to reverse the effects on growth,
and providing specific micronutrients results in a better weight
and height gain, and reversal of growth faltering over and
above of macronutrients [30]. Growth faltering thus poten-
tially is a functional outcome of a combination of both protein
energy malnutrition and multiple micronutrients deficiency,
which may explain lack of impact on growth in a recent zinc
fortification trial [31]. The dietary intake data of enrolled
children are presented in supplementary Tables S2, S3
and S4.
Finally, improvement in body iron stores, decrease in anemia
and improvement in growth points towards a global improve-
ment in child’s health - a functional endpoint of multiple
metabolic processes. This global improvement could be due to a
combination of effects of individual constituents of the interven-
tion and/or synergistic effects among the components. Given the
design of the study we cannot attribute effects to a specific
component but only describe the collective impact of the specific
micronutrient bundle tested as the experimental intervention in
this study.
In our study, we had criteria to exclude children allergic to milk;
however, no such child was encountered. The results of the study
cannot be generalized to populations, which may have high rates
of lactose intolerance or milk allergy. These conditions in
preschool children are rare in most developing country popula-
tions especially in Asia. The findings of this study cannot be
directly extrapolated to fortification of other foods with similar
bundle as the absorption of nutrients may vary with the kind of
food being fortified.
The study provides evidence that delivery of critical
micronutrients especially zinc and iron via food based vehicle,
milk in this instance, is a feasible option and produces impact
on growth, anemia and iron status similar to or better than that
observed in supplementation trials. It provides a potential
strategy for achieving Millennium Development Goals [32]
targeted for reduction in mortality, morbidity and malnutrition
among children. Further investigation of the effectiveness of
the micronutrient-fortified milk is warranted, including cost-
effectiveness before any program recommendation can be
made.
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Table S1 Effect of fortification on anthropometric parameters
among fortified milk vs. control milk group children at mid-study
(after 6 months of intervention).
Found at: doi:10.1371/journal.pone.0012167.s001 (0.04 MB
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Table S2 Macronutrient and micronutrient intake of the
enrolled children at baseline.
Found at: doi:10.1371/journal.pone.0012167.s002 (0.03 MB
DOC)
Table S3 Macronutrient and micronutrient intake (including the
intake from milk supplement) of the enrolled children at mid-study
(after 6 months of intervention).
Found at: doi:10.1371/journal.pone.0012167.s003 (0.03 MB
DOC)
Table S4 Macronutrient and micronutrient intake (including the
intake from milk supplement) of the enrolled children at end-study
(after 12 months of intervention).
Found at: doi:10.1371/journal.pone.0012167.s004 (0.03 MB
DOC)
Checklist S1 Consort Statement 2001 - Checklist.
Found at: doi:10.1371/journal.pone.0012167.s005 (0.06 MB
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Protocol S1 Protocol for Efficacy Study of Milk Fortified with
Bifidobacillus lactis HNO19 and Oligosaccharides or Zinc and
Iron and other Micronutrients.
Found at: doi:10.1371/journal.pone.0012167.s006 (0.27 MB
DOC)
Table 5. Effect of micronutrient fortified milk on hematological parameters and plasma zinc status among fortified milk vs. control
milk group children after 1 year of intervention.
Variables MN Group (n=233)
a Co Group (n=232)
a Difference of means (95% CI) p value
Hb
c (g/L) 109.0611.4
b 95.4615.4 13.6 (11.1 to 16.0) ,0.001
Hct
d (%) 35.963.2 32.664.0 3.3 (2.7 to 4.0) ,0.001
ZnPP
e (mmol/mole heme) 79.7668.8 176.86130.9 297.1 (2116.1 to 278.0) ,0.001
RDW
f (%) 16.062.1 18.562.6 22.5 (22.9 to 22.1) ,0.001
sFr (mg/L) 15.3611.2 9.868.6 5.5 (3.5 to 7.4) ,0.001
sTfr (mg/ml) 7.364.4 11.767.0 24.4 (25.5 to 23.3) ,0.001
Plasma zinc (mg/dL) 61.4626.8 63.4629.4 21.97 (27.3 to 3.3) 0.47
Iron deficient anemic 31 (13.3)
g 128 (55.2) 0.12 (0.08 to 0.20)
h ,0.001
aEnd-study hematological data and plasma zinc levels were available for 233 and 232 children in the MN and Co group respectively.
bMean6standard deviation.
cHemoglobin.
dHematocrit.
eZinc protoporphyrin.
fRed cell distribution width.
gNumber (%).
hOdds ratio (95% CI).
doi:10.1371/journal.pone.0012167.t005
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